Pharmaceutical Business review

BRNI To Collaborate With Brain Injury Group

The Blanchette Rockefeller Neurosciences Institute (BRNI) has entered into an agreement with a group of neurological specialists (Brain Injury Group), to examine possible confluences of the Group’s work with brain injuries, head trauma, and strokes and BRNI’s research.

 

Reportedly, the companies will jointly explore the correlation between these injuries and various debilitating neurological disorders, such as Alzheimer’s disease and other forms of dementia.

 

Brain Injury Group will work with BRNI scientists to research the full effects of chronic traumatic encephalopathy (CTE) and similar brain injuries, how they affect the brain on a physical and neurological scale and their connections with neurological disorders.

 

Moreover, the goal will be to develop new ways to prevent and treat brain trauma and its long-lasting degenerative consequences.

 

Additionally, as part of the agreement, BRNI and the Brain Injury Group will develop a ‘brain bank’ that will reside at the Institute. Brains of athletes and others who suffered from head trauma and neurological disorders of varying stages will be studied and tested for treatments.

 

Daniel Alkon, scientific director of BRNI, said: The Blanchette Rockefeller Neurosciences Institute is honored to explore the vast combinations of our human memory science and the important brain injury research of Dr. Bailes and Dr. Omalu. Together, we will uncover the potential links between brain injury and diseases and disorders of human memory, including Alzheimer’s disease.